TY  - GEN
AU  - Menke-van der Houven van Oordt,C Willemien
AU  - Gomez-Roca,Carlos
AU  - van Herpen,Carla
AU  - Coveler,Andrew L
AU  - Mahalingam,Devalingam
AU  - Verheul,Henk M W
AU  - van der Graaf,Winette T A
AU  - Christen,Randolph
AU  - Rüttinger,Dominik
AU  - Weigand,Stefan
AU  - Cannarile,Michael A
AU  - Heil,Florian
AU  - Brewster,Michael
AU  - Walz,Antje-Christine
AU  - Nayak,Tapan K
AU  - Guarin,Ernesto
AU  - Meresse,Valerie
AU  - Le Tourneau,Christophe
TI  - First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors
SN  - 1949-2553
PY  - 2018///0215
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - adverse effects
KW  - Antineoplastic Agents, Immunological
KW  - Disease Progression
KW  - Female
KW  - Humans
KW  - Hyaluronan Receptors
KW  - genetics
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasms
KW  - drug therapy
KW  - Pilot Projects
KW  - Positron-Emission Tomography
KW  - Radiopharmaceuticals
KW  - pharmacokinetics
KW  - Tissue Distribution
KW  - Zirconium
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study
UR  - https://doi.org/10.18632/oncotarget.11098
ER  -